nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfametopyrazine—Sulfisoxazole—EDNRA—coronary artery disease	0.453	0.453	CrCbGaD
Sulfametopyrazine—Sulfamethazine—ALB—coronary artery disease	0.0943	0.0943	CrCbGaD
Sulfametopyrazine—Dapsone—MPO—coronary artery disease	0.094	0.094	CrCbGaD
Sulfametopyrazine—Sulfamerazine—ALB—coronary artery disease	0.0922	0.0922	CrCbGaD
Sulfametopyrazine—Sulfamethizole—ALB—coronary artery disease	0.0715	0.0715	CrCbGaD
Sulfametopyrazine—Sulfanilamide—CYP2C19—coronary artery disease	0.0634	0.0634	CrCbGaD
Sulfametopyrazine—Dapsone—CYP2C19—coronary artery disease	0.0566	0.0566	CrCbGaD
Sulfametopyrazine—Sulfamethoxazole—ALB—coronary artery disease	0.0401	0.0401	CrCbGaD
Sulfametopyrazine—Dapsone—PTGS2—coronary artery disease	0.0352	0.0352	CrCbGaD
